HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

human MIRN623 microRNA

Also Known As:

MIRN623 microRNA, human; hsa-mir-623; miR-623, human; microRNA-623, human

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleic Acids: 11752
  - RNA: 69704
    - Untranslated RNA: 2850
      - Small Untranslated RNA: 566
        MicroRNAs: 67298
        human MIRN623 microRNA: 5
    - Antisense RNA: 1599
      - MicroRNAs: 67298
        human MIRN623 microRNA: 5
- Antisense Elements (Genetics): 31
  - Antisense RNA: 1599
    - MicroRNAs: 67298
      - human MIRN623 microRNA: 5

Experts

1.	Fu, Sheng-Ling: 4 articles (01/2019 - 01/2016)
2.	Liu, Xian-Sheng: 4 articles (01/2019 - 01/2016)
3.	Wei, Shuang: 4 articles (01/2019 - 01/2016)
4.	Xie, Jun-Gang: 4 articles (01/2019 - 01/2016)
5.	Xiong, Wei-Ning: 4 articles (01/2019 - 01/2016)
6.	Xu, Yong-Jian: 4 articles (01/2019 - 01/2016)
7.	Zhang, Zun-Yi: 4 articles (01/2019 - 01/2016)
8.	Zhao, Jian-Ping: 4 articles (01/2019 - 01/2016)
9.	Cen, Hong: 1 article (07/2019)
10.	Chen, Yinting: 1 article (07/2019)

Related Diseases

1.	Lung Neoplasms (Lung Cancer) 01/01/2016 - "Our previous study revealed that Ku80 was overexpressed in lung cancer tissues and hsa-miR-623 regulated the Ku80 expression; however, the detailed function of hsa-miR-623 in lung cancer was unclear. " 01/01/2016 - "In summary, our results showed that hsa-miR-623 was downregulated in lung adenocarcinoma and suppressed the invasion and metastasis targeting Ku80 through ERK/JNK inactivation mediated downregulation of MMP-2/9. These findings reveal that hsa-miR-623 may serve as an important therapeutic target in lung cancer therapy."
2.	Neoplasms (Cancer) 01/01/2019 - "Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma." 08/06/2018 - "Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma." 01/01/2017 - "Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma." 01/01/2016 - "Ku80 knockdown in lung adenocarcinoma cells suppressed tumor properties in vitro and in vivo similar to hsa-miR-623 overexpression. " 01/01/2016 - "Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma."
3.	Adenocarcinoma of Lung 01/01/2016 - "Hsa-miR-623 suppressed lung adenocarcinoma cell proliferation, clonogenicity, migration and invasion in vitro. " 01/01/2016 - "Downregulation of hsa-miR-623 was associated with poor clinical outcomes of lung adenocarcinoma patients. " 01/01/2016 - "Hsa-miR-623 was downregulated in lung adenocarcinoma tissues compared with corresponding non-tumorous tissues, and its expression was inversely correlated with Ku80 upregulation. " 01/01/2019 - "Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma." 08/06/2018 - "Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma."
4.	Neoplasm Metastasis (Metastasis) 01/01/2016 - "Hsa-miR-623 inhibited xenografts growth and metastasis of lung adenocarcinoma in vivo. " 07/01/2019 - "MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer." 01/01/2016 - "In summary, our results showed that hsa-miR-623 was downregulated in lung adenocarcinoma and suppressed the invasion and metastasis targeting Ku80 through ERK/JNK inactivation mediated downregulation of MMP-2/9. These findings reveal that hsa-miR-623 may serve as an important therapeutic target in lung cancer therapy."
5.	Pancreatic Neoplasms (Pancreatic Cancer) 07/01/2019 - "MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer."

Related Drugs and Biologics

1.	MAP Kinase Kinase 4
2.	MicroRNAs (MicroRNA)
3.	Matrix Metalloproteinases (MMPs)
4.	Messenger RNA (mRNA)
5.	Phosphotransferases (Kinase)

Related Therapies and Procedures

1.	Therapeutics